APO Research
Talk to an analyst

APO RESEARCH · REPORT

Axial Spondyloarthritis Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Axial Spondyloarthritis Drugs Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchAxial Spondyloarthritis Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Axial Spondyloarthritis Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Axial Spondyloarthritis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Axial Spondyloarthritis Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Axial Spondyloarthritis Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Axial Spondyloarthritis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Axial Spondyloarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Axial Spondyloarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Axial Spondyloarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Axial Spondyloarthritis Drugs include Johnson & Johnson, Novartis AG, Eli Lilly and Company, AstraZeneca Plc, UCB SA, Sun Pharma Advanced Research Company Ltd, Sandoz International GmbH and Panacea Biotec Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Axial Spondyloarthritis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Axial Spondyloarthritis Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Axial Spondyloarthritis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Axial Spondyloarthritis Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Axial Spondyloarthritis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Axial Spondyloarthritis Drugs Market by Company

Johnson & Johnson

Novartis AG

Eli Lilly and Company

AstraZeneca Plc

UCB SA

Sun Pharma Advanced Research Company Ltd

Sandoz International GmbH

Panacea Biotec Ltd

Axial Spondyloarthritis Drugs Segment by Type

Ixekizumab

Secukinumab

Certolizumab Pegol

Etanercept Biosimilar

Others

Axial Spondyloarthritis Drugs Segment by Application

Clinic

Hospital

Home Care

Axial Spondyloarthritis Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Axial Spondyloarthritis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Axial Spondyloarthritis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Axial Spondyloarthritis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Axial Spondyloarthritis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Axial Spondyloarthritis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ixekizumab Table 2. Major Company of Secukinumab Table 3. Major Company of Certolizumab Pegol Table 4. Major Company of Etanercept Biosimilar Table 5. Major Company of Others Table 6. Global Axial Spondyloarthritis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Axial Spondyloarthritis Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Axial Spondyloarthritis Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Axial Spondyloarthritis Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Axial Spondyloarthritis Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Axial Spondyloarthritis Drugs Industry Trends Table 28. Axial Spondyloarthritis Drugs Industry Drivers Table 29. Axial Spondyloarthritis Drugs Industry Opportunities and Challenges Table 30. Axial Spondyloarthritis Drugs Industry Restraints Table 31. Global Axial Spondyloarthritis Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Axial Spondyloarthritis Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Axial Spondyloarthritis Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Axial Spondyloarthritis Drugs Sales Share by Company (2021-2026) Table 35. Global Axial Spondyloarthritis Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Axial Spondyloarthritis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Axial Spondyloarthritis Drugs Major Company Production Sites and Headquarters Table 38. Global Axial Spondyloarthritis Drugs Company, Product Type & Application Table 39. Global Axial Spondyloarthritis Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Axial Spondyloarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Axial Spondyloarthritis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Axial Spondyloarthritis Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Axial Spondyloarthritis Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Axial Spondyloarthritis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Axial Spondyloarthritis Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Axial Spondyloarthritis Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Axial Spondyloarthritis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Axial Spondyloarthritis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Axial Spondyloarthritis Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Axial Spondyloarthritis Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Axial Spondyloarthritis Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Axial Spondyloarthritis Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Axial Spondyloarthritis Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Axial Spondyloarthritis Drugs Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Novartis AG Company Information Table 80. Novartis AG Business Overview Table 81. Novartis AG Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Novartis AG Axial Spondyloarthritis Drugs Product Portfolio Table 83. Novartis AG Recent Development Table 84. Eli Lilly and Company Company Information Table 85. Eli Lilly and Company Business Overview Table 86. Eli Lilly and Company Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Eli Lilly and Company Axial Spondyloarthritis Drugs Product Portfolio Table 88. Eli Lilly and Company Recent Development Table 89. AstraZeneca Plc Company Information Table 90. AstraZeneca Plc Business Overview Table 91. AstraZeneca Plc Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AstraZeneca Plc Axial Spondyloarthritis Drugs Product Portfolio Table 93. AstraZeneca Plc Recent Development Table 94. UCB SA Company Information Table 95. UCB SA Business Overview Table 96. UCB SA Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. UCB SA Axial Spondyloarthritis Drugs Product Portfolio Table 98. UCB SA Recent Development Table 99. Sun Pharma Advanced Research Company Ltd Company Information Table 100. Sun Pharma Advanced Research Company Ltd Business Overview Table 101. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product Portfolio Table 103. Sun Pharma Advanced Research Company Ltd Recent Development Table 104. Sandoz International GmbH Company Information Table 105. Sandoz International GmbH Business Overview Table 106. Sandoz International GmbH Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sandoz International GmbH Axial Spondyloarthritis Drugs Product Portfolio Table 108. Sandoz International GmbH Recent Development Table 109. Panacea Biotec Ltd Company Information Table 110. Panacea Biotec Ltd Business Overview Table 111. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product Portfolio Table 113. Panacea Biotec Ltd Recent Development Table 114. North America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Axial Spondyloarthritis Drugs Sales by Country (2021-2026) & (K Units) Table 116. North America Axial Spondyloarthritis Drugs Sales Market Share by Country (2021-2026) Table 117. North America Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Axial Spondyloarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 119. North America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Axial Spondyloarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Axial Spondyloarthritis Drugs Market Share by Country (2021-2026) Table 122. North America Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Axial Spondyloarthritis Drugs Market Share Forecast by Country (2027-2032) Table 124. Europe Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Axial Spondyloarthritis Drugs Sales by Country (2021-2026) & (K Units) Table 126. Europe Axial Spondyloarthritis Drugs Sales Market Share by Country (2021-2026) Table 127. Europe Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Axial Spondyloarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Axial Spondyloarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Axial Spondyloarthritis Drugs Market Share by Country (2021-2026) Table 132. Europe Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Axial Spondyloarthritis Drugs Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Axial Spondyloarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Axial Spondyloarthritis Drugs Market Share by Country (2021-2026) Table 142. Asia-Pacific Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Axial Spondyloarthritis Drugs Market Share Forecast by Country (2027-2032) Table 144. Latin America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Axial Spondyloarthritis Drugs Sales by Country (2021-2026) & (K Units) Table 146. Latin America Axial Spondyloarthritis Drugs Sales Market Share by Country (2021-2026) Table 147. Latin America Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Axial Spondyloarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Axial Spondyloarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Axial Spondyloarthritis Drugs Market Share by Country (2021-2026) Table 152. Latin America Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Axial Spondyloarthritis Drugs Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Axial Spondyloarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Axial Spondyloarthritis Drugs Market Share by Country (2021-2026) Table 162. Middle East and Africa Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Axial Spondyloarthritis Drugs Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Axial Spondyloarthritis Drugs Distributors List Table 167. Axial Spondyloarthritis Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Axial Spondyloarthritis Drugs Image Figure 2. Global Axial Spondyloarthritis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Axial Spondyloarthritis Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Axial Spondyloarthritis Drugs Sales (2021-2032) & (K Units) Figure 5. Ixekizumab Image Figure 6. Global Ixekizumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Secukinumab Image Figure 8. Global Secukinumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Certolizumab Pegol Image Figure 10. Global Certolizumab Pegol Sales YoY Growth (2021-2032) & (K Units) Figure 11. Etanercept Biosimilar Image Figure 12. Global Etanercept Biosimilar Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Axial Spondyloarthritis Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Axial Spondyloarthritis Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Axial Spondyloarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Axial Spondyloarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Axial Spondyloarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Axial Spondyloarthritis Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Home Care Image Figure 34. Global Home Care Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Axial Spondyloarthritis Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Axial Spondyloarthritis Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Axial Spondyloarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Axial Spondyloarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Axial Spondyloarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Axial Spondyloarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Axial Spondyloarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Axial Spondyloarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Axial Spondyloarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Axial Spondyloarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Axial Spondyloarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Axial Spondyloarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Axial Spondyloarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Axial Spondyloarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Axial Spondyloarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Axial Spondyloarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Axial Spondyloarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Axial Spondyloarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Axial Spondyloarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Axial Spondyloarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Axial Spondyloarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Axial Spondyloarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Axial Spondyloarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Axial Spondyloarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Axial Spondyloarthritis Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Axial Spondyloarthritis Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ixekizumab
  • Secukinumab
  • Certolizumab Pegol
  • Etanercept Biosimilar
  • Others
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Eli Lilly and Company
  • AstraZeneca Plc
  • UCB SA
  • Sun Pharma Advanced Research Company Ltd
  • Sandoz International GmbH
  • Panacea Biotec Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Axial Spondyloarthritis Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Axial Spondyloarthritis Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Axial Spondyloarthritis Drugs Market by Type
  6. 1.3.1 Ixekizumab
  7. 1.3.2 Secukinumab
  8. 1.3.3 Certolizumab Pegol
  9. 1.3.4 Etanercept Biosimilar
  10. 1.3.5 Others
  11. 1.4 Global Axial Spondyloarthritis Drugs Market Size by Type
  12. 1.4.1 Global Axial Spondyloarthritis Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Axial Spondyloarthritis Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Axial Spondyloarthritis Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Axial Spondyloarthritis Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Axial Spondyloarthritis Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Axial Spondyloarthritis Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Axial Spondyloarthritis Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Axial Spondyloarthritis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Axial Spondyloarthritis Drugs Industry Trends
  2. 2.2 Axial Spondyloarthritis Drugs Industry Drivers
  3. 2.3 Axial Spondyloarthritis Drugs Industry Opportunities and Challenges
  4. 2.4 Axial Spondyloarthritis Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Axial Spondyloarthritis Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Axial Spondyloarthritis Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Axial Spondyloarthritis Drugs Price (2021-2026)
  4. 3.4 Global Axial Spondyloarthritis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Axial Spondyloarthritis Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Axial Spondyloarthritis Drugs Company, Product Type & Application
  7. 3.7 Global Axial Spondyloarthritis Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Axial Spondyloarthritis Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Axial Spondyloarthritis Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Axial Spondyloarthritis Drugs Tier 1, Tier 2, and Tier 3
4 Axial Spondyloarthritis Drugs Regional Status and Outlook
  1. 4.1 Global Axial Spondyloarthritis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Axial Spondyloarthritis Drugs Historic Market Size by Region
  3. 4.2.1 Global Axial Spondyloarthritis Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Axial Spondyloarthritis Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Axial Spondyloarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Axial Spondyloarthritis Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Axial Spondyloarthritis Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Axial Spondyloarthritis Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Axial Spondyloarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Axial Spondyloarthritis Drugs by Application
  1. 5.1 Axial Spondyloarthritis Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Home Care
  5. 5.2 Global Axial Spondyloarthritis Drugs Market Size by Application
  6. 5.2.1 Global Axial Spondyloarthritis Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Axial Spondyloarthritis Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Axial Spondyloarthritis Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Axial Spondyloarthritis Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Axial Spondyloarthritis Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Axial Spondyloarthritis Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Axial Spondyloarthritis Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Axial Spondyloarthritis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Axial Spondyloarthritis Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Axial Spondyloarthritis Drugs Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Axial Spondyloarthritis Drugs Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 AstraZeneca Plc
  20. 6.4.1 AstraZeneca Plc Company Information
  21. 6.4.2 AstraZeneca Plc Business Overview
  22. 6.4.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Plc Axial Spondyloarthritis Drugs Product Portfolio
  24. 6.4.5 AstraZeneca Plc Recent Developments
  25. 6.5 UCB SA
  26. 6.5.1 UCB SA Company Information
  27. 6.5.2 UCB SA Business Overview
  28. 6.5.3 UCB SA Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UCB SA Axial Spondyloarthritis Drugs Product Portfolio
  30. 6.5.5 UCB SA Recent Developments
  31. 6.6 Sun Pharma Advanced Research Company Ltd
  32. 6.6.1 Sun Pharma Advanced Research Company Ltd Company Information
  33. 6.6.2 Sun Pharma Advanced Research Company Ltd Business Overview
  34. 6.6.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product Portfolio
  36. 6.6.5 Sun Pharma Advanced Research Company Ltd Recent Developments
  37. 6.7 Sandoz International GmbH
  38. 6.7.1 Sandoz International GmbH Company Information
  39. 6.7.2 Sandoz International GmbH Business Overview
  40. 6.7.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sandoz International GmbH Axial Spondyloarthritis Drugs Product Portfolio
  42. 6.7.5 Sandoz International GmbH Recent Developments
  43. 6.8 Panacea Biotec Ltd
  44. 6.8.1 Panacea Biotec Ltd Company Information
  45. 6.8.2 Panacea Biotec Ltd Business Overview
  46. 6.8.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product Portfolio
  48. 6.8.5 Panacea Biotec Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Axial Spondyloarthritis Drugs Sales by Country
  2. 7.1.1 North America Axial Spondyloarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Axial Spondyloarthritis Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Axial Spondyloarthritis Drugs Market Size by Country
  6. 7.2.1 North America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Axial Spondyloarthritis Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Axial Spondyloarthritis Drugs Sales by Country
  2. 8.1.1 Europe Axial Spondyloarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Axial Spondyloarthritis Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Axial Spondyloarthritis Drugs Market Size by Country
  6. 8.2.1 Europe Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Axial Spondyloarthritis Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Axial Spondyloarthritis Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Axial Spondyloarthritis Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Axial Spondyloarthritis Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Axial Spondyloarthritis Drugs Sales by Country
  2. 10.1.1 South America Axial Spondyloarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Axial Spondyloarthritis Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Axial Spondyloarthritis Drugs Market Size by Country
  6. 10.2.1 South America Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Axial Spondyloarthritis Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Axial Spondyloarthritis Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Axial Spondyloarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Axial Spondyloarthritis Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Axial Spondyloarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Axial Spondyloarthritis Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Axial Spondyloarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Axial Spondyloarthritis Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Axial Spondyloarthritis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Axial Spondyloarthritis Drugs Value Chain Analysis
  2. 12.1.1 Axial Spondyloarthritis Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Axial Spondyloarthritis Drugs Production Mode & Process
  7. 12.2 Axial Spondyloarthritis Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Axial Spondyloarthritis Drugs Distributors
  10. 12.2.3 Axial Spondyloarthritis Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst